Skip to main content
. 2023 Mar 30;18(4):999–1014. doi: 10.1016/j.stemcr.2023.03.001

Figure 6.

Figure 6

WNT7A suppresses fatty infiltration in skeletal muscle

(A) Experimental timeline outlining in vivo glycerol injection, WNT7A administration, and analyses. Created with BioRender.

(B) Representative cross-sections of glycerol-injured TA muscles treated with WNT7A or saline. Scale bars: 500 μm.

(C) Perilipin area normalized by the TA cross-sectional area. Two-tailed unpaired t test. ∗p = 0.027.

(D) Median fiber cross-sectional area. Two-tailed unpaired t test.

(E) Histogram of fiber cross-sectional area. Mean ± SEM.